Search results

• Vatalanib
  ...amilies called protein tyrosine kinase inhibitors and VEGF receptor kinase inhibitors.  ...amilies called protein tyrosine kinase inhibitors and VEGF receptor kinase inhibitors. Also called PTK787/ZK 222584 {{dictionary-stub}} [[Category:Dictionary of
  606 bytes (77 words) - 19:16, 13 January 2023
• PTK787/ZK 222584
  ...amilies called protein tyrosine kinase inhibitors and VEGF receptor kinase inhibitors.  ...amilies called protein tyrosine kinase inhibitors and VEGF receptor kinase inhibitors. Also called vatalanib {{dictionary-stub}} [[Category:Dictionary of medicin
  576 bytes (79 words) - 10:42, 13 January 2023
• EGFR tyrosine kinase inhibitor
  |Term=EGFR tyrosine kinase inhibitor |Short definition=EGFR tyrosine kinase inhibitor (.
  872 bytes (124 words) - 11:53, 11 January 2023
• Larotrectinib
  ...the treatment of solid [[tumors]] with a [[neurotrophic tyrosine receptor kinase]] (NTRK) gene fusion. It is marketed under the brand name '''Vitrakvi'''. ...ec' for [[receptor]], and 'tinib' is a common suffix for [[tyrosine kinase inhibitors]].
  2 KB (204 words) - 04:36, 7 February 2024
• Epidermal growth factor receptor tyrosine kinase inhibitor
  |Term=epidermal growth factor receptor tyrosine kinase inhibitor ...tance that blocks the activity of a protein called epidermal growth factor receptor (EGFR). EGFR is found on the surface of some normal cells and is involved i
  1 KB (174 words) - 12:58, 11 January 2023
• CP-724,714
  ...tment of cancer. It belongs to the family of ErbB receptor tyrosine kinase inhibitors  ...tment of cancer. It belongs to the family of ErbB receptor tyrosine kinase inhibitors {{dictionary-stub}} [[Category:Dictionary of medicine]]
  452 bytes (63 words) - 08:36, 11 January 2023
• EGFR inhibitor
  ...th factor receptor inhibitor and epidermal growth factor receptor tyrosine kinase inhibitor {{dictionary-stub}} [[Category:Dictionary of medicine]]
  801 bytes (116 words) - 11:55, 11 January 2023
• Olmutinib
  ...Olmu, and the suffix -tinib, which is commonly used for [[tyrosine kinase inhibitors]], a class of drugs that Olmutinib belongs to. Olmutinib is used to treat patients with metastatic [[epidermal growth factor receptor]] (EGFR) T790M mutation-positive non-small cell lung cancer (NSCLC), who ha
  1 KB (190 words) - 19:44, 5 February 2024
• Neratinib
  ...(a type of tumor) and "tinib" which is a common suffix for tyrosine kinase inhibitors. ...th of cancer cells. Specifically, it inhibits the activity of the HER2/neu receptor, a protein that is overexpressed in some types of breast cancer.
  1 KB (200 words) - 19:54, 5 February 2024
• Gilteritinib
  ...ting the [[FMS-like tyrosine kinase 3]] (FLT3) and [[AXL receptor tyrosine kinase]] (AXL). ...he words "Gilt", "Eri", and "Tinib". "Tinib" is a common suffix for kinase inhibitors. The origin of "Gilt" and "Eri" is not clearly known.
  2 KB (241 words) - 00:15, 7 February 2024
• Saracatinib
  ...straZeneca, and the class of drugs it belongs to, known as tyrosine kinase inhibitors. The "-tinib" suffix is common among this class of drugs. ...ase inhibitor]]: A type of drug that blocks the action of enzymes known as tyrosine kinases, which can promote the growth of cancer cells.
  1 KB (190 words) - 00:18, 7 February 2024
• Zanubrutinib
  ...t the [[Bruton's tyrosine kinase]] (BTK), a crucial enzyme in the [[B-cell receptor]] signaling pathway. This drug is used in the treatment of [[B-cell maligna ...sine kinase, the target of the drug, and 'nib' is a suffix used for kinase inhibitors.
  1 KB (195 words) - 02:52, 7 February 2024
• Motesanib
  ...r]]. It is a [[small molecule inhibitor]] that targets multiple [[receptor tyrosine kinases]]. ...rived from "molecule", and "-sanib" is a common suffix for tyrosine kinase inhibitors.
  1 KB (163 words) - 20:22, 5 February 2024
• Vascular endothelial growth factor receptor
  == Vascular Endothelial Growth Factor Receptor (VEGFR) == ...rds 'vasculum' meaning 'vessel', 'endothelium' meaning 'inner layer', and 'receptor' meaning 'receiver'.
  2 KB (272 words) - 22:24, 13 February 2024
• Janus
  ...For example, Janus Kinase (JAK) is a family of intracellular, non-receptor tyrosine kinases that transduce cytokine-mediated signals via the JAK-STAT pathway. ==== Janus Kinase ====
  2 KB (253 words) - 04:38, 4 February 2024
• Erlotinib
  ...e kinase inhibitor]], specifically targeting the [[epidermal growth factor receptor]] (EGFR). ...a subsidiary of Roche. The "tinib" suffix is common among tyrosine kinase inhibitors.
  2 KB (230 words) - 17:01, 5 February 2024
• Epidermal growth factor receptor inhibitor
  |Term=epidermal growth factor receptor inhibitor ...nce that inhibits the activity of a protein called epidermal growth factor receptor (EGFR) blocked. EGFR is found on the surface of some normal cells and is in
  1 KB (166 words) - 18:52, 11 January 2023
• Tivantinib
  ...ix indicates that the drug works by inhibiting the activity of one or more tyrosine kinases, enzymes that play a key role in the signaling pathways that regula ...is a non-[[ATP]] competitive inhibitor of the [[c-Met]] receptor tyrosine kinase. By inhibiting c-Met, Tivantinib disrupts the signaling pathways that promo
  2 KB (235 words) - 14:38, 6 February 2024
• Rociletinib
  ...e EGFR gene that have become resistant to first and second-generation EGFR inhibitors. ...ibute to the company, while "tinib" is a common suffix for tyrosine kinase inhibitors, which is the class of drugs to which Rociletinib belongs.
  2 KB (221 words) - 17:42, 6 February 2024
• Crenolanib
  ...s a potent and selective inhibitor of the [[platelet-derived growth factor receptor]] (PDGFR) that has shown promise in the treatment of [[acute myeloid leukem ...cals. The suffix "-nib" is commonly used in the names of [[tyrosine kinase inhibitors]], which is the class of drugs that Crenolanib belongs to.
  1 KB (193 words) - 02:22, 6 February 2024

View (previous 20 | next 20) (20 | 50 | 100 | 250 | 500)